IZO.CN
Price:
$0.05
Market Cap:
$2.62M
Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and 3D CT breast imaging platform for the earlier detection and diagnosis of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2018-06-06
Stock Exchange
CNQ
Ticker
IZO.CN
According to Izotropic Corporation’s latest financial reports and current stock price. The company's current ROE is 60.53%. This represents a change of 306.97% compared to the average of 14.87% of the last 4 quarters.
The mean historical ROE of Izotropic Corporation over the last ten years is 197.51%. The current 60.53% ROE has changed -69.35% with respect to the historical average. Over the past ten years (40 quarters), IZO.CN's ROE was at its highest in in the April 2022 quarter at 438.43%. The ROE was at its lowest in in the January 2022 quarter at -592.23%.
Average
197.51%
Median
-34.78%
Minimum
-179.06%
Maximum
1.78%
Discovering the peaks and valleys of Izotropic Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 29.93%
Maximum Annual ROE = 1.78%
Minimum Annual Increase = -1717.49%
Minimum Annual ROE = -179.06%
Year | ROE | Change |
---|---|---|
2024 | 40.59% | -77.96% |
2023 | 184.18% | -89.66% |
2022 | 1.78% | -1717.49% |
2021 | -110.16% | -32.60% |
2020 | -163.43% | 29.93% |
2019 | -125.78% | -29.75% |
2018 | -179.06% | -217.78% |
The current ROE of Izotropic Corporation (IZO.CN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
668.84%
5-year avg
346.59%
10-year avg
197.51%
Izotropic Corporation’s ROE is less than Izotropic Corporation (60.53%), less than Cognetivity Neurosciences Ltd. (27.85%), less than VentriPoint Diagnostics Ltd. (1.36%), less than TAAT Global Alternatives Inc. (1.60%), greater than Christina Lake Cannabis Corp. (-43.11%),
Company | ROE | Market cap |
---|---|---|
60.53% | $2.44M | |
27.85% | $895.89K | |
1.36% | $22.60M | |
1.60% | $1.90M | |
-43.11% | $3.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Izotropic Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Izotropic Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Izotropic Corporation's ROE?
How is the ROE calculated for Izotropic Corporation (IZO.CN)?
What is the highest ROE for Izotropic Corporation (IZO.CN)?
What is the 3-year average ROE for Izotropic Corporation (IZO.CN)?
What is the 5-year average ROE for Izotropic Corporation (IZO.CN)?
How does the current ROE for Izotropic Corporation (IZO.CN) compare to its historical average?